Product Reports Resources Pricing Login Book a demo
Investor profile

Perceptive Advisors

Private Equity, Venture Capital · Founded 2018 · New York City, United States

Focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologies in healthcare

159 portfolio companies Private Equity, Venture Capital · $23B invested · 288 investments · Investor rank #107 · Last investment 8/2026
Portfolio companies 159 ↑ 63% 5y
Decacorns 5
Thoroughbreds 39 ↑ 43% 5y
01 · Biggest holdings

Perceptive Advisors’ biggest current holdings.

The most valuable companies Perceptive Advisors still holds — unicorns and thoroughbreds it has backed, ordered by Dealroom’s latest valuation. Companies that have been acquired or gone public are in Exits instead. Where a cap table names Perceptive Advisors directly, the stake and its estimated value are shown too.

#CompanyEst. stakeValuationEst. value
  1. 1 KindbodyUnicorn · Health · USA 23.5% $1.8B $423M
  2. 2 TalkiatryUnicorn · Health · USA $1.4B
  3. 3 InsightecUnicorn · Health · Israel 5% $1.3B $65M
  4. 4 HonorUnicorn · Health · USA $1.2B

Estimated value = Perceptive Advisors’ disclosed ownership % × Dealroom’s latest company valuation; direct named stakes only, exited positions excluded. Figures are indicative, not reported marks. See the underlying cap tables on Dealroom →

02 · Exits

Perceptive Advisors’ biggest exits.

Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from Perceptive Advisors’ transaction record.

$2.0B IPO · 2019
Entered Series B+Now $18BHealth
IPO · 2020
Entered Series B+Now $12BHealth
$707M IPO · 2021
Entered Series B+Now $8.9BHealth
$391M IPO · 2018
Entered Series B+Now $7.8BHealth
$1.3B IPO · 2020
Now $6.9BHealth
$350M IPO · 2018
Now $6.7BHealth
$494M IPO · 2025
Entered Series B+Now $6.1BHealth
$840M IPO · 2021
Now $4.3BHealth
$433M IPO · 2019
Now $3.8BHealth
$311M IPO · 2023
Entered Series B+Now $3.7BHealth
$1.7B IPO · 2020
Entered Series B+Now $3.5BHealth
IPO · 2019
Entered Series B+Now $3.3BHealth
03 · Portfolio analysis

Where Perceptive Advisors’ portfolio is concentrated.

Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 159 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.

By countryCount
  1. USA213
  2. UK11
  3. France6
  4. Canada4
  5. China4
  6. Germany2
  7. Switzerland2
  8. Australia1
  9. Belgium1
  10. Denmark1
  11. India1
  12. Ireland1
By sectorCount
  1. Health241
  2. Enterprise Software3
  3. Wellness Beauty2
  4. Food1
  5. Jobs Recruitment1
  6. Robotics1
  7. Transportation1
By stage enteredCount
  1. Series B+104
  2. Series A29
  3. Seed2
By growth stageCount
  1. Late Growth172
  2. Breakout Stage54
  3. Early Growth22
  4. Mature2
04 · Portfolio market map

Inside Perceptive Advisors’ portfolio.

The 60 highest-funded portfolio companies, of 159 tracked.

Freenome
Health · Unicorn
$1.3B
Caris Life Sciences
Health · Unicorn
$6.1B
Cue
Health
Zymergen
Health
$226M
I-Mab Biopharma
Health
$186M
GeneDx Inc
Health · Unicorn
$2.3B
Insightec
Health · Unicorn
$1.3B
BridgeBio
Health · Decacorn
$18B
Bicycle Therapeutics
Health
Cerevel Therapeutics
Health · Unicorn
$6.9B
Saluda Medical
Health
$501M
Imperative Care
Health · Unicorn
$1.3B
Impulse Dynamics
Health
$632M
Sema4
Health · Unicorn
$2.0B
Zenefits
Jobs Recruitment
$200M
Outset Medical
Health
$48M
Kardigan
Health · Unicorn
$1.6B
Relay Therapeutics
Health · Unicorn
$3.5B
Allogene Therapeutics
Health
$500M
Avidity Biosciences
Health · Decacorn
$12B
Saama Technologies
Health
$160M
Solid Biosciences
Health
$541M
Immatics biotechnologies
Health
$814M
DNAnexus
Health
$600M
Crinetics Pharmaceuticals
Health · Unicorn
$7.8B
Synthego
Health
$800M
Oruka Therapeutics
Health
SpringWorks Therapeutics
Health · Unicorn
$3.3B
Omada Health
Health · Unicorn
$1.2B
Galecto | Damora Therapeutics
Health · Unicorn
$1.9B
Enjoy
Transportation · Unicorn
$1.2B
RayzeBio
Health · Unicorn
$3.7B
Pear Therapeutics
Health
$690K
Talkiatry
Health · Unicorn
$1.4B
COMPASS Pathways
Health · Unicorn
$1.4B
Ocular Therapeutix
Health · Unicorn
$1.5B
Avalyn Pharma
Health · Unicorn
$1.4B
Acerta Pharma
Health · Unicorn
$7.0B
Thrive Earlier Detection
Health · Unicorn
$2.2B
Day One Biopharmaceuticals
Health · Unicorn
$1.8B
Affinivax
Health · Unicorn
$2.1B
Capstan Therapeutics
Health · Unicorn
$2.1B
Pyxis Oncology
Health
$214M
Poseida Therapeutics
Health
$778M
PROCEPT BioRobotics
Health · Unicorn
$1.0B
Honor
Health · Unicorn
$1.3B
Viridian Therapeutics
Health · Unicorn
$1.9B
Zenas BioPharma
Health · Unicorn
$1.6B
Sonendo
Health
$11M
Neuron23
Health
$500M
LianBio
Health
Orchard Therapeutics
Health
$303M
Alto Neuroscience
Health
$874M
Kindbody
Health · Unicorn
$1.8B
Nautilus
Health
$59M
Endeavor BioMedicines
Health
$530M
Adlai Nortye
Health
$874M
Sionna Therapeutics
Health · Unicorn
$2.1B
Cogent Biosciences
Health · Unicorn
$6.7B
Beta Bionics
Health
$204M
05 · Portfolio founders

Where Perceptive Advisors’ portfolio founders come from.

161 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.

LocationCount
  1. United States119
  2. United Kingdom11
  3. Australia3
  4. Denmark3
  5. Netherlands3
  6. China2
  7. France2
  8. Germany2
  9. India2
  10. Israel2
UniversityCount
  1. Stanford University11
  2. Massachusetts Institute of Technology8
  3. Columbia University5
  4. Harvard Business School5
  5. Harvard University5
  6. Yale University5
  7. Dartmouth College4
  8. Harvard Medical School4
  9. University of California, Berkeley4
  10. University College London3
Previous companyCount
  1. Bristol-Myers Squibb4
  2. Lehman Brothers4
  3. MyoKardia4
  4. Novartis4
  5. Sanofi Aventis4
  6. Alphabet | Google3
  7. Genentech3
  8. Harvard Medical School3
  9. Merck & Co.3
  10. Alantos Pharmaceuticals2